Top Markets
Coin of the day
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Rank in Stocks #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Share Price
$1.34
Last synced: 2024-02-14
Market Cap
$48.96M
Change (1 day)
-12.94%
Change (1 year)
0.00%
Country
SE
Trade Promore Pharma AB (publ) (PROMO)

Category

Stock price history for Promore Pharma AB (publ) (PROMO)
Highest end of day price: $2.11 on 2024-02-01

Lowest end of day price: $179.71 on 2017-07-01
Stock price history of Promore Pharma AB (publ) from 2017 to 2026
Annual Stock Price Performance
Year Performance
2024 54.03%
2023 -86.45%
2022 -51.13%
2021 -52.08%
2020 -18.70%
2019 -67.83%
2018 -5.69%
2017 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.33 -18.49%
AU
$761.87 8.65%
CH
$130.43 397.46%
US